Key clinical point:
Major finding: Adverse birth outcomes were lower when HIV positive women were on isoniazid to prevent tuberculosis during pregnancy (16% vs. 28%; P = 0.08).
Study details: Observational study of 151 women
Disclosures: The work was funded by the National Institutes of Health. The lead investigator did not have any disclosures.
Salazar-Austin NM et al. CROI 2019, Abstract.